Research study Program year 2019 Source: CMS Open Payments

Efficacy and Safety Study of Apremilast CC-10004 in Pediatric Subjects From 6 Through 17 Years of Age With Moderate to Severe Plaque Psor

Research payments

$11,678

12 payments

Through program year 2019, $11,678 in research payments was reported against Efficacy and Safety Study of Apremilast CC-10004 in Pediatric Subjects From 6 Through 17 Years of Age With Moderate to Severe Plaque Psor, across 12 payments, paid by Amgen Inc..

Paid by: Amgen Inc.
ClinicalTrials.gov: No trial number was reported for this study

By program year

1 row

Year	Kind	Amount	Payments
2019	Research	$11,678	12

Breakdown

Who paid Research payments · program year 2019

Amgen Inc. $11,678 12 payments

Who received the money Research payments · program year 2019

Clinical Trials Research Institute Organisation paid for research $4,327 1 payment
Solutions Through Advanced Research Inc. Organisation paid for research $4,213 2 payments
The Board of Regents of the University of Wisconsin System Organisation paid for research $1,744 1 payment
Johnson Dermatology Clinic Organisation paid for research $461 1 payment
University Of Miami Hospital Organisation paid for research $461 1 payment
University Of Wisconsin Hospital And Clinics Organisation paid for research $111 1 payment
Dawes Fretzin Dermatology Group INC Organisation paid for research $100 1 payment
First Oc Dermatology Organisation paid for research $81 1 payment
Driscoll Childrens Hospital Teaching hospital · TX $81 1 payment
Skin Care Physicians Of Georgia Organisation paid for research $50 1 payment

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

9 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.